Understanding suicidal intent in drug overdose deaths
Suicidal intent in fatal drug overdoses
This study looks at how we can tell the difference between accidental and intentional drug overdoses by examining various reports and data, and it's aimed at helping people understand the reasons behind these tragic deaths in areas where drug use is a big problem.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10880425 on NIH RePORTER |
What this research studies
This research investigates the classification of intent in fatal drug overdoses, particularly distinguishing between accidental and suicidal deaths. By analyzing data from death certificates, toxicology reports, and coroner investigations, the study aims to identify factors that influence how these deaths are classified. The research employs a mixed methods approach, combining quantitative data analysis with linguistic analysis to better understand the complexities surrounding drug overdose fatalities. The focus is on a specific region with high rates of drug abuse, utilizing national databases to gather comprehensive insights.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced substance use issues or suicidal ideation, particularly in regions with high drug overdose rates.
Not a fit: Patients who have not experienced substance use or suicidal thoughts may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate classifications of drug overdose deaths, potentially improving mental health interventions and support for at-risk populations.
How similar studies have performed: Previous research has indicated that understanding the nuances of intent in drug-related fatalities can lead to improved public health strategies, suggesting that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Lundberg, Alexander — Northwestern University at Chicago
- Study coordinator: Lundberg, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.